Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
Biography and Research Information
OverviewAI-generated summary
Tripti Shukla's research focuses on health sciences, with recent work examining the association between sensorineural hearing loss and neurocognitive performance in survivors of childhood cancer. This systematic review and meta-analysis involved synthesizing data from multiple studies to assess this relationship. Shukla has also contributed to research on real-world cardiovascular outcomes for patients with type 2 diabetes treated with combined SGLT2 inhibitor and GLP1 receptor agonist therapies, as well as comparing Inclisiran with PCSK9 monoclonal antibodies in individuals with hyperlipidemia. Her scholarly activity includes one total publication, and she collaborates with researchers at the University of Arkansas for Medical Sciences, including Robert Spraggins, Buthainah Alhwarat, Brad Fugere, and Landon Bruich.
Metrics
- Publications: 1
Selected Publications
-
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)
-
1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia (2026)
-
Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis (2025)
Collaboration Network
Top Collaborators
Robert Spraggins
University of Arkansas for Medical Sciences
2 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
Buthainah Alhwarat
University of Arkansas for Medical Sciences
2 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
Brad Fugere
University of Arkansas for Medical Sciences
2 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
Bhupendar Tayal
University of Arkansas for Medical Sciences
2 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
Jennifer Schlak
University of Minnesota (US)
1 shared publication
- Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis
Anne Eaton
University of Minnesota (US)
1 shared publication
- Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis
Lindsay Blake
University of Arkansas for Medical Sciences
1 shared publication
In database
- Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis
Alicia Kunin‐Batson
University of Minnesota (US)
1 shared publication
- Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis
Ellen van der Plas
Arkansas Children's Hospital
1 shared publication
In database
- Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis
Keshav Garg
University of Arkansas for Medical Sciences
1 shared publication
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
Khalid Sawalha
University of Arkansas for Medical Sciences
1 shared publication
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
Aakash Rana
Central Arkansas Veterans Healthcare System (US)
1 shared publication
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
Munthir Mansour
University of Arkansas for Medical Sciences
1 shared publication
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
Landon Bruich
University of Arkansas for Medical Sciences
1 shared publication
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
Mohab Elnashar
University of Arkansas for Medical Sciences
1 shared publication
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
Similar Researchers
Based on overlapping research topics
Kristine Patterson
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Cardiovascular Function and Risk Factors
RanjithKumar Sivakumar
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Cardiovascular Function and Risk Factors
Steven Metzer
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Cardiovascular Function and Risk Factors
Ahmad Mustafa
University of Arkansas at Fayetteville
Meta-analysis and systematic reviews
Cardiovascular Function and Risk Factors
Kaitlyn N. Walden
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Cardiovascular Function and Risk Factors
Mahesh Bavineni
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Cardiovascular Function and Risk Factors